| Investment Value | ₹60 CrCapital Expenditure |
|---|---|
| Capacity Addition | 93 LakhUnits Per Annum |
| Market Cap | ₹1,059.5 CrMid-range Performer |
| PE TTM | 24.55Industry PE 24.34 |
| Deal value | ₹60 Cr |
| Share of market cap | 5.7% |
| Share of annual revenue | 12.5% |
Key highlights
- Board approved ₹60 crore investment for an additional manufacturing facility in Bharuch
- Production capacity will scale from ~15 lakh units to ~108 lakh units per annum
- Commercial production from the new facility is scheduled to begin by March 2027
- Expansion is necessitated by high existing capacity utilization of approximately 87%
- Project to be funded through a combination of internal accruals and borrowings
The Bharuch Expansion Plan
Borosil Scientific is scaling its manufacturing footprint in Gujarat by adding a secondary production unit adjacent to its existing Bharuch facility. The project involves a substantial ramp-up in glassware production, moving from the current 15 lakh units per annum to a projected 108 lakh units. The existing facility currently operates at approximately 87% utilization, signaling limited headroom for further growth without this capital infusion.
The company expects the new plant to be fully operational and ready for commercial production by the end of the 2027 fiscal year, effectively increasing its output by over 600%.
Strategic Rationale and Revenue Model
The expansion is specifically tailored to service Borosil Limited (BL), the company's primary client for these glassware lines. This long-standing manufacturing arrangement serves as a predictable revenue stream and allows Borosil Scientific to optimize its machinery and infrastructure utilization. By augmenting capacity seven-fold, the company aims to capture the increasing sourcing requirements from BL’s consumer and labware segments.
Furthermore, the company intends to leverage the Viksit Gujarat Industrial Policy 2026 to apply for capital subsidies, which could potentially enhance the project's long-term financial viability.
Financial Context and Market Position
Borosil Scientific operates with a trailing twelve-month (TTM) revenue of ₹478.12 crore and a net profit of ₹43.15 crore. The ₹60 crore investment represents a significant capital commitment relative to its annual operating cash flow of ₹43.27 crore, necessitating a mix of internal accruals and debt. The stock currently trades at a P/E of 24.55, which is closely aligned with the industry average of 24.34.
The Indian scientific and labware market is seeing steady growth driven by increased R&D spending in the pharmaceutical and education sectors, supporting the demand for high-quality borosilicate glassware.
Business Overview
- Primary Focus: Manufacturing of scientific labware, pharmaceutical primary packaging, and consumer glassware components
- Strategic Relationship: Operates as a key manufacturing partner for Borosil Limited, a dominant brand in Indian consumer glassware
- Quality Standards: Specializes in USP Type 1 borosilicate glass, essential for chemical resistance in laboratory settings
- Geographic Concentration: Maintains high-efficiency production clusters in Gujarat to benefit from regional logistics and industrial gas supply chains
| Share price | ₹119.11 |
|---|---|
| Market capitalisation | ₹1,059.50 Cr |
| Revenue (annual) | ₹467.34 Cr |
| Net profit (annual) | ₹34.61 Cr |
| Revenue (latest quarter) | ₹106.75 Cr-25.44% vs previous quarter |
| Net profit (latest quarter) | ₹4.37 Cr-83.94% vs previous quarter |
| P/E (TTM) | 24.55×Sector 42.14× |
| Promoter holding | 68.27%+0.19% QoQ |
| FII holding | 0.23%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Borosil Scientific Limited announcing board approval for capacity expansion in Bharuch, Gujarat. Market figures from a third-party data provider.
